![Roger Garceau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roger Garceau
Director/Miembro de la Junta en ENTERA BIO LTD. .
Fortuna: 103 845 $ al 31/05/2024
Cargos activos de Roger Garceau
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ENTERA BIO LTD. | Director/Miembro de la Junta | 01/03/2016 | - |
Director Ejecutivo | 10/08/2020 | 04/01/2021 | |
PROTARA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/01/2019 | - |
Independent Dir/Board Member | 01/01/2019 | - | |
Fluorinov Pharmaceuticals, Inc.
![]() Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Director/Miembro de la Junta | 04/05/2015 | - |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Miembro de la Junta | 01/12/2016 | - |
Independent Dir/Board Member | 01/12/2016 | - |
Historial de carrera de Roger Garceau
Antiguos cargos conocidos de Roger Garceau.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NPS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 11/06/2009 | 01/02/2015 |
Ventas & Marketing | 11/12/2008 | 11/06/2009 | |
ArTara Subsidiary, Inc.
![]() ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Director/Miembro de la Junta | 01/01/2019 | - |
Formación de Roger Garceau.
Fairfield University | Undergraduate Degree |
UMass Chan Medical School | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Francia | 2 |
Israel | 2 |
Operativa
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ENTERA BIO LTD. | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
NPS Pharmaceuticals, Inc.
![]() NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Fluorinov Pharmaceuticals, Inc.
![]() Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Health Technology |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
ArTara Subsidiary, Inc.
![]() ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Roger Garceau
- Experiencia